位置:首页 > 蛋白库 > THSD1_HUMAN
THSD1_HUMAN
ID   THSD1_HUMAN             Reviewed;         852 AA.
AC   Q9NS62; A2A3J3; B2RCF5; Q6P3U1; Q6UXZ2;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 148.
DE   RecName: Full=Thrombospondin type-1 domain-containing protein 1;
DE   AltName: Full=Transmembrane molecule with thrombospondin module;
DE   Flags: Precursor;
GN   Name=THSD1; Synonyms=TMTSP; ORFNames=UNQ3010/PRO9769;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Hiroyama T., Atsushi I., Yukio N., Hiromitsu N.;
RT   "Transmembrane molecule with thrombospondin module.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN ANIB12, VARIANTS ANIB12 PHE-5; 450-ARG--ILE-852 DEL;
RP   TRP-460; GLY-466; GLU-600; LEU-639; ILE-653 AND PRO-775, CHARACTERIZATION
RP   OF VARIANTS ANIB12 PHE-5; 450-ARG--ILE-852 DEL; TRP-460; GLY-466; GLU-600;
RP   LEU-639; ILE-653 AND PRO-775, FUNCTION, AND INTERACTION WITH TLN1.
RX   PubMed=27895300; DOI=10.1161/strokeaha.116.014161;
RA   Santiago-Sim T., Fang X., Hennessy M.L., Nalbach S.V., DePalma S.R.,
RA   Lee M.S., Greenway S.C., McDonough B., Hergenroeder G.W., Patek K.J.,
RA   Colosimo S.M., Qualmann K.J., Hagan J.P., Milewicz D.M., MacRae C.A.,
RA   Dymecki S.M., Seidman C.E., Seidman J.G., Kim D.H.;
RT   "THSD1 (thrombospondin type 1 domain containing protein 1) mutation in the
RT   pathogenesis of intracranial aneurysm and subarachnoid emorrhage.";
RL   Stroke 47:3005-3013(2016).
RN   [8]
RP   ERRATUM OF PUBMED:27895300.
RA   Santiago-Sim T., Fang X., Hennessy M.L., Nalbach S.V., DePalma S.R.,
RA   Lee M.S., Greenway S.C., McDonough B., Hergenroeder G.W., Patek K.J.,
RA   Colosimo S.M., Qualmann K.J., Hagan J.P., Milewicz D.M., MacRae C.A.,
RA   Dymecki S.M., Seidman C.E., Seidman J.G., Kim D.H.;
RT   "THSD1 (thrombospondin type 1 domain containing protein 1) mutation in the
RT   pathogenesis of intracranial aneurysm and subarachnoid emorrhage.";
RL   Stroke 48:e240-e240(2016).
RN   [9]
RP   INVOLVEMENT IN ANIB12, CHARACTERIZATION OF VARIANTS ANIB12 TRP-460;
RP   GLY-466; GLU-600; LEU-639; ILE-653 AND PRO-775, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, AND INTERACTION WITH TLN1.
RX   PubMed=29069646; DOI=10.1159/000484298;
RA   Rui Y.N., Xu Z., Fang X., Menezes M.R., Balzeau J., Niu A., Hagan J.P.,
RA   Kim D.H.;
RT   "The Intracranial Aneurysm Gene THSD1 Connects Endosome Dynamics to Nascent
RT   Focal Adhesion Assembly.";
RL   Cell. Physiol. Biochem. 43:2200-2211(2017).
CC   -!- FUNCTION: Is a positive regulator of nascent focal adhesion assembly,
CC       involved in the modulation of endothelial cell attachment to the
CC       extracellular matrix. {ECO:0000269|PubMed:27895300,
CC       ECO:0000269|PubMed:29069646}.
CC   -!- SUBUNIT: Part of a complex composed of THSD1, PTK2/FAK1, TLN1 and VCL
CC       (PubMed:29069646). Interacts with TLN1 (PubMed:27895300,
CC       PubMed:29069646). {ECO:0000269|PubMed:27895300,
CC       ECO:0000269|PubMed:29069646}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Endosome membrane
CC       {ECO:0000269|PubMed:29069646}; Single-pass type I membrane protein
CC       {ECO:0000305}. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:29069646}. Note=Localizes to nascent focal
CC       adhesions. {ECO:0000269|PubMed:29069646}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NS62-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NS62-2; Sequence=VSP_020521;
CC       Name=3;
CC         IsoId=Q9NS62-3; Sequence=VSP_020522, VSP_020523;
CC   -!- DISEASE: Aneurysm, intracranial berry, 12 (ANIB12) [MIM:618734]: A form
CC       of cerebral aneurysm, a focal abnormal dilatation of a blood vessel in
CC       the brain. Berry intracranial aneurysms, also known as saccular
CC       aneurysms, have a characteristic rounded shape and account for the vast
CC       majority of intracranial aneurysms. They are the most common cause of
CC       non-traumatic subarachnoid hemorrhage, a sudden-onset disease that can
CC       lead to severe disability and death. Several risk factors such as
CC       smoking, hypertension, and excessive alcohol intake are associated with
CC       subarachnoid hemorrhage. {ECO:0000269|PubMed:27895300,
CC       ECO:0000269|PubMed:29069646}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB044385; BAA96553.1; -; mRNA.
DR   EMBL; AY358149; AAQ88516.1; -; mRNA.
DR   EMBL; AK315087; BAG37552.1; -; mRNA.
DR   EMBL; AL359513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471274; EAW55891.1; -; Genomic_DNA.
DR   EMBL; CH471274; EAW55894.1; -; Genomic_DNA.
DR   EMBL; BC063842; AAH63842.1; -; mRNA.
DR   CCDS; CCDS9432.1; -. [Q9NS62-1]
DR   CCDS; CCDS9433.1; -. [Q9NS62-2]
DR   RefSeq; NP_061146.1; NM_018676.3. [Q9NS62-1]
DR   RefSeq; NP_954872.1; NM_199263.2. [Q9NS62-2]
DR   AlphaFoldDB; Q9NS62; -.
DR   BioGRID; 120988; 2.
DR   CORUM; Q9NS62; -.
DR   IntAct; Q9NS62; 2.
DR   STRING; 9606.ENSP00000258613; -.
DR   GlyGen; Q9NS62; 10 sites, 2 O-linked glycans (3 sites).
DR   iPTMnet; Q9NS62; -.
DR   PhosphoSitePlus; Q9NS62; -.
DR   BioMuta; THSD1; -.
DR   DMDM; 74752936; -.
DR   EPD; Q9NS62; -.
DR   jPOST; Q9NS62; -.
DR   MassIVE; Q9NS62; -.
DR   PaxDb; Q9NS62; -.
DR   PeptideAtlas; Q9NS62; -.
DR   PRIDE; Q9NS62; -.
DR   ProteomicsDB; 82492; -. [Q9NS62-1]
DR   ProteomicsDB; 82493; -. [Q9NS62-2]
DR   ProteomicsDB; 82494; -. [Q9NS62-3]
DR   Antibodypedia; 2452; 235 antibodies from 23 providers.
DR   DNASU; 55901; -.
DR   Ensembl; ENST00000258613.5; ENSP00000258613.4; ENSG00000136114.17. [Q9NS62-1]
DR   Ensembl; ENST00000349258.8; ENSP00000340650.4; ENSG00000136114.17. [Q9NS62-2]
DR   Ensembl; ENST00000648254.1; ENSP00000497520.1; ENSG00000136114.17. [Q9NS62-2]
DR   GeneID; 55901; -.
DR   KEGG; hsa:55901; -.
DR   MANE-Select; ENST00000258613.5; ENSP00000258613.4; NM_018676.4; NP_061146.1.
DR   UCSC; uc001vgo.4; human. [Q9NS62-1]
DR   CTD; 55901; -.
DR   DisGeNET; 55901; -.
DR   GeneCards; THSD1; -.
DR   HGNC; HGNC:17754; THSD1.
DR   HPA; ENSG00000136114; Low tissue specificity.
DR   MalaCards; THSD1; -.
DR   MIM; 616821; gene.
DR   MIM; 618734; phenotype.
DR   neXtProt; NX_Q9NS62; -.
DR   OpenTargets; ENSG00000136114; -.
DR   Orphanet; 231160; Familial cerebral saccular aneurysm.
DR   Orphanet; 363999; Non-immune hydrops fetalis.
DR   PharmGKB; PA134937912; -.
DR   VEuPathDB; HostDB:ENSG00000136114; -.
DR   eggNOG; ENOG502QY3P; Eukaryota.
DR   GeneTree; ENSGT00390000013335; -.
DR   HOGENOM; CLU_336470_0_0_1; -.
DR   InParanoid; Q9NS62; -.
DR   OMA; RNMETWS; -.
DR   PhylomeDB; Q9NS62; -.
DR   TreeFam; TF333148; -.
DR   PathwayCommons; Q9NS62; -.
DR   Reactome; R-HSA-5083635; Defective B3GALTL causes PpS.
DR   Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins.
DR   SignaLink; Q9NS62; -.
DR   BioGRID-ORCS; 55901; 7 hits in 1064 CRISPR screens.
DR   ChiTaRS; THSD1; human.
DR   GeneWiki; THSD1; -.
DR   GenomeRNAi; 55901; -.
DR   Pharos; Q9NS62; Tbio.
DR   PRO; PR:Q9NS62; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9NS62; protein.
DR   Bgee; ENSG00000136114; Expressed in ventricular zone and 101 other tissues.
DR   ExpressionAtlas; Q9NS62; baseline and differential.
DR   Genevisible; Q9NS62; HS.
DR   GO; GO:0071944; C:cell periphery; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; IMP:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0050840; F:extracellular matrix binding; IMP:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IDA:UniProtKB.
DR   Gene3D; 2.20.100.10; -; 1.
DR   InterPro; IPR038877; THSD1.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR16311; PTHR16311; 1.
DR   Pfam; PF00090; TSP_1; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Disease variant; Disulfide bond;
KW   Endosome; Glycoprotein; Membrane; Phosphoprotein; Reference proteome;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..852
FT                   /note="Thrombospondin type-1 domain-containing protein 1"
FT                   /id="PRO_0000249584"
FT   TOPO_DOM        25..413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        414..434
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        435..852
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          340..393
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   REGION          444..517
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          624..799
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        457..471
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        637..665
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        667..686
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        687..714
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        768..799
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM61"
FT   CARBOHYD        39
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        58
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        69
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        304
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        352..387
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        356..392
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        367..377
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   VAR_SEQ         341..393
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020521"
FT   VAR_SEQ         394..429
FT                   /note="AFQPSSPSPLQPQGPVKSNNIVTVTGISLCLFIIIA -> GGFSLCCPGWSA
FT                   VARSWLTTSSASRVHAILLPQPPE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_020522"
FT   VAR_SEQ         430..852
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_020523"
FT   VARIANT         5
FT                   /note="L -> F (in ANIB12; loss of function in endothelial
FT                   cell-matrix adhesion; undetectable protein expression;
FT                   dbSNP:rs1380388780)"
FT                   /evidence="ECO:0000269|PubMed:27895300"
FT                   /id="VAR_083714"
FT   VARIANT         125
FT                   /note="V -> G (in dbSNP:rs13313279)"
FT                   /id="VAR_027474"
FT   VARIANT         224
FT                   /note="R -> G (in dbSNP:rs9536062)"
FT                   /id="VAR_027475"
FT   VARIANT         450..852
FT                   /note="Missing (in ANIB12; loss of function in endothelial
FT                   cell-matrix adhesion)"
FT                   /evidence="ECO:0000269|PubMed:27895300"
FT                   /id="VAR_083715"
FT   VARIANT         460
FT                   /note="R -> W (in ANIB12; unknown pathological
FT                   significance; decreased function in endothelial cell-matrix
FT                   adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs776400380)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083716"
FT   VARIANT         466
FT                   /note="E -> G (in ANIB12; unknown pathological
FT                   significance; loss of function in endothelial cell-matrix
FT                   adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs201805081)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083717"
FT   VARIANT         491
FT                   /note="D -> H (in dbSNP:rs56013270)"
FT                   /id="VAR_061920"
FT   VARIANT         600
FT                   /note="G -> E (in ANIB12; unknown pathological
FT                   significance; loss of function in endothelial cell-matrix
FT                   adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs141140186)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083718"
FT   VARIANT         639
FT                   /note="P -> L (in ANIB12; decreased function in endothelial
FT                   cell-matrix adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs1024014523)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083719"
FT   VARIANT         653
FT                   /note="T -> I (in ANIB12; unknown pathological
FT                   significance; loss of function in endothelial cell-matrix
FT                   adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs371717283)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083720"
FT   VARIANT         768
FT                   /note="K -> R (in dbSNP:rs9536041)"
FT                   /id="VAR_027476"
FT   VARIANT         775
FT                   /note="S -> P (in ANIB12; unknown pathological
FT                   significance; loss of function in endothelial cell-matrix
FT                   adhesion; decreased interaction with TLN1;
FT                   dbSNP:rs780150341)"
FT                   /evidence="ECO:0000269|PubMed:27895300,
FT                   ECO:0000269|PubMed:29069646"
FT                   /id="VAR_083721"
SQ   SEQUENCE   852 AA;  94584 MW;  597461CFDDC07147 CRC64;
     MKPMLKDFSN LLLVVLCDYV LGEAEYLLLR EPGHVALSND TVYVDFQYFD GANGTLRNVS
     VLLLEANTNQ TVTTKYLLTN QSQGTLKFEC FYFKEAGDYW FTMTPEATDN STPFPWWEKS
     AFLKVEWPVF HVDLNRSAKA AEGTFQVGLF TSQPLCPFPV DKPNIVVDVI FTNSLPEARR
     NSRQPLEIRT SKRTELAQGQ WVEFGCAPLG PEAYVTVVLK LLGRDSVITS TGPIDLAQKF
     GYKLVMVPEL TCESGVEVTV LPPPCTFVQG VVTVFKEAPR YPGKRTIHLA ENSLPLGERR
     TIFNCTLFDM GKNKYCFDFG ISSRSHFSAK EECMLIQRNT ETWGLWQPWS QCSATCGDGV
     RERRRVCLTS FPSSPVCPGM SLEASLCSLE ECAAFQPSSP SPLQPQGPVK SNNIVTVTGI
     SLCLFIIIAT VLITLWRRFG RPAKCSTPAR HNSIHSPSFR KNSDEENICE LSEQRGSFSD
     GGDGPTGSPG DTGIPLTYRR SGPVPPEDDA SGSESFQSNA QKIIPPLFSY RLAQQQLKEM
     KKKGLTETTK VYHVSQSPLT DTAIDAAPSA PLDLESPEEA AANKFRIKSP FPEQPAVSAG
     ERPPSRLDLN VTQASCAISP SQTLIRKSQA RHVGSRGGPS ERSHARNAHF RRTASFHEAR
     QARPFRERSM STLTPRQAPA YSSRTRTCEQ AEDRFRPQSR GAHLFPEKLE HFQEASGTRG
     PLNPLPKSYT LGQPLRKPDL GDHQAGLVAG IERTEPHRAR RGPSPSHKSV SRKQSSPISP
     KDNYQRVSSL SPSQCRKDKC QSFPTHPEFA FYDNTSFGLT EAEQRMLDLP GYFGSNEEDE
     TTSTLSVEKL VI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025